|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: NOVA PHARMACEUTICAL INC, SB-2, EX-24, 2000-06-05 |
Next: DEVON ENERGY CORP/DE, 8-K, 2000-06-05 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-31-2000
<PERIOD-END> MAR-31-2000
<CASH> 0
<SECURITIES> 0
<RECEIVABLES> 83,325
<ALLOWANCES> 0
<INVENTORY> 35,172
<CURRENT-ASSETS> 2,407,131
<PP&E> 43,116
<DEPRECIATION> 0
<TOTAL-ASSETS> 3,317,051
<CURRENT-LIABILITIES> 964,570
<BONDS> 0
<COMMON> 15,509
0
0
<OTHER-SE> 2,319,324
<TOTAL-LIABILITY-AND-EQUITY> 3,317,051
<SALES> 166,399
<TOTAL-REVENUES> 166,399
<CGS> 72,422
<TOTAL-COSTS> 72,422
<OTHER-EXPENSES> 692,055
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 535,380
<INCOME-PRETAX> (1,133,458)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,133,458)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,133,458)
<EPS-BASIC> (.07)
<EPS-DILUTED> (.07)
</TABLE>
|
|